Top Stories
Latest Coverage
Ropeginterferon Alfa-2b, a Major Hematology Drug, Expands Its Indications: Essential Thrombocythemia
On October 15, 2026, the official website of China’s National Medical Products Administration (NMPA) indicated that r...
On October 15, 2026, the official website of China’s National Medical Products Administration (NMPA) indicated that r...
Understanding the Global Pharmaceutical Supply Chain: How Medicines Cross Markets and Borders
Access to medicines is an important issue in global healthcare. For patients, pharmacies, and healthcare institutions...
Access to medicines is an important issue in global healthcare. For patients, pharmacies, and healthcare institutions...
Zongertinib vs. Sevabertinib: Two Major Breakthroughs in HER2-Mutant Lung Cancer Treatment — What Are the Key Differences?
Beginning in 2025, zongertinib became the first oral targeted therapy approved worldwide for HER2-mutant NSCLC. Sevab...
Beginning in 2025, zongertinib became the first oral targeted therapy approved worldwide for HER2-mutant NSCLC. Sevab...
From Intravenous Infusion to Oral Administration: Paclitaxel Oral Solution Gains a New Indication for Breast Cancer
In October 2026, a new development in the formulation of anticancer medicines emerged in China. On October 8, paclita...
In October 2026, a new development in the formulation of anticancer medicines emerged in China. On October 8, paclita...
KRAS Mutations and Precision Oncology: From KRAS G12C Inhibitors to Next-Generation RAS-Targeted Therapies
One of the key goals of precision oncology is to identify more targeted treatment strategies based on the molecular c...
One of the key goals of precision oncology is to identify more targeted treatment strategies based on the molecular c...
Global First-in-Class Drug Approved in China: Vosoritide Brings Disease-Modifying Treatment to Children with Achondroplasia
On September 18, 2026, the official website of China’s National Medical Products Administration (NMPA) announced that...
On September 18, 2026, the official website of China’s National Medical Products Administration (NMPA) announced that...